These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 24197987)
1. Vision specific quality of life in children with optic pathway gliomas. Avery RA; Hardy KK J Neurooncol; 2014 Jan; 116(2):341-7. PubMed ID: 24197987 [TBL] [Abstract][Full Text] [Related]
2. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program. Dalla Via P; Opocher E; Pinello ML; Calderone M; Viscardi E; Clementi M; Battistella PA; Laverda AM; Da Dalt L; Perilongo G Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361 [TBL] [Abstract][Full Text] [Related]
3. Visual acuity of children treated with chemotherapy for optic pathway gliomas. Kalin-Hajdu E; Décarie JC; Marzouki M; Carret AS; Ospina LH Pediatr Blood Cancer; 2014 Feb; 61(2):223-7. PubMed ID: 23956233 [TBL] [Abstract][Full Text] [Related]
4. Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1. Wan MJ; Ullrich NJ; Manley PE; Kieran MW; Goumnerova LC; Heidary G J Neurooncol; 2016 Aug; 129(1):173-8. PubMed ID: 27311725 [TBL] [Abstract][Full Text] [Related]
5. Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1. de Blank PM; Berman JI; Liu GT; Roberts TP; Fisher MJ Neuro Oncol; 2013 Aug; 15(8):1088-95. PubMed ID: 23658320 [TBL] [Abstract][Full Text] [Related]
6. Handheld optical coherence tomography during sedation in young children with optic pathway gliomas. Avery RA; Hwang EI; Ishikawa H; Acosta MT; Hutcheson KA; Santos D; Zand DJ; Kilburn LB; Rosenbaum KN; Rood BR; Schuman JS; Packer RJ JAMA Ophthalmol; 2014 Mar; 132(3):265-71. PubMed ID: 24435762 [TBL] [Abstract][Full Text] [Related]
7. Optic pathway glioma in children: does visual deficit correlate with radiology in focal exophytic lesions? Aquilina K; Daniels DJ; Spoudeas H; Phipps K; Gan HW; Boop FA Childs Nerv Syst; 2015 Nov; 31(11):2041-9. PubMed ID: 26277358 [TBL] [Abstract][Full Text] [Related]
8. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients. Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859 [TBL] [Abstract][Full Text] [Related]
9. Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas. Avery RA; Bouffet E; Packer RJ; Reginald A Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1034-8. PubMed ID: 23329671 [TBL] [Abstract][Full Text] [Related]
10. Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Fisher MJ; Loguidice M; Gutmann DH; Listernick R; Ferner RE; Ullrich NJ; Packer RJ; Tabori U; Hoffman RO; Ardern-Holmes SL; Hummel TR; Hargrave DR; Bouffet E; Charrow J; Bilaniuk LT; Balcer LJ; Liu GT Neuro Oncol; 2012 Jun; 14(6):790-7. PubMed ID: 22474213 [TBL] [Abstract][Full Text] [Related]
11. Neurofibromatosis Type 1-Associated Optic Pathway Glioma in Children: A Follow-Up of 10 Years or More. Kinori M; Armarnik S; Listernick R; Charrow J; Zeid JL Am J Ophthalmol; 2021 Jan; 221():91-96. PubMed ID: 32283094 [TBL] [Abstract][Full Text] [Related]
12. Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision. de Blank PMK; Fisher MJ; Liu GT; Gutmann DH; Listernick R; Ferner RE; Avery RA J Neuroophthalmol; 2017 Sep; 37 Suppl 1(Suppl 1):S23-S32. PubMed ID: 28806346 [TBL] [Abstract][Full Text] [Related]
13. Ganglion cell layer-inner plexiform layer thickness and vision loss in young children with optic pathway gliomas. Gu S; Glaug N; Cnaan A; Packer RJ; Avery RA Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1402-8. PubMed ID: 24519429 [TBL] [Abstract][Full Text] [Related]
14. Neurofibromatosis type 1-associated optic pathway gliomas: pathogenesis and emerging treatments. Amato A; Imbimbo BP; Falsini B Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5636-5653. PubMed ID: 37401302 [TBL] [Abstract][Full Text] [Related]
15. The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1. Prada CE; Hufnagel RB; Hummel TR; Lovell AM; Hopkin RJ; Saal HM; Schorry EK J Pediatr; 2015 Oct; 167(4):851-856.e1. PubMed ID: 26233602 [TBL] [Abstract][Full Text] [Related]
16. Optic pathway gliomas in children with and without neurofibromatosis 1. Czyzyk E; Jóźwiak S; Roszkowski M; Schwartz RA J Child Neurol; 2003 Jul; 18(7):471-8. PubMed ID: 12940652 [TBL] [Abstract][Full Text] [Related]
17. Automatic Visual Acuity Loss Prediction in Children with Optic Pathway Gliomas using Magnetic Resonance Imaging. Jiang Z; Parida A; Anwar SM; Tang Y; Roth HR; Fisher MJ; Packer RJ; Avery RA; Linguraru MG Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-5. PubMed ID: 38083430 [TBL] [Abstract][Full Text] [Related]
18. Visual field outcomes in children treated for neurofibromatosis type 1-associated optic pathway gliomas: a multicenter retrospective study. Heidary G; Fisher MJ; Liu GT; Ferner RE; Gutmann DH; Listernick RH; Kapur K; Loguidice M; Ardern-Holmes SL; Avery RA; Hammond C; Hoffman RO; Hummel TR; Kuo A; Reginald A; Ullrich NJ J AAPOS; 2020 Dec; 24(6):349.e1-349.e5. PubMed ID: 33221469 [TBL] [Abstract][Full Text] [Related]